Skip to main content
. 2013 Jan 9;6:23–38. doi: 10.2147/JPR.S36827

Figure 2.

Figure 2

Participant flow-diagram.

Notes: Participant flow-diagram of the study illustrating patient enrollment, inclusion, the two study days and analysis. The intention-to-treat (ITT) and per-protocol (PP) groups were 33/33 (females/males) and 13/14, respectively.